Traverse Biotech, Inc is a biotechnology startup based in the United States that focuses on accelerating the development of international therapeutic innovation within the NYC ecosystem. With the slogan "Accelerating development of international therapeutic innovation in the NYC ecosystem," Traverse Biotech aims to develop innovative internationally sourced technologies from the pre-clinical stage through clinical proof-of-concept. This approach is poised to drive significant value for shareholders and maximize patient benefit.
The company's most recent investment, a grant investment received on 18 October 2023, came from the National Cancer Institute. This marked investment serves as a testament to the potential and promise of Traverse Biotech's innovative approach to biotechnology development.